MOBILion Systems Inc. has launched of its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, which addresses characterization challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides fast..
Pharmaceutical Industry News
Immunicom, Inc., a global biotech company that is redefining immuno-oncology with breakthrough non-pharmaceutical subtractive immunotherapy treatments designed to preserve quality-of-life while being treated, presented preliminary data from its late-stage..
Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, today unveiled the Aria Smart Autoinjector platform to unlock innovation, differentiation and sustainability in the digital drug-delivery device market.
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule.
3M Food Safety today introduces the 3M™ Environmental Scrub Sampler with 10 mL Wide Spectrum Neutralizer, an innovative solution for environmental microbial sampling applications.
Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS).
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for infectious diseases.
Intelliscan 3D is revolutionizing the industry with a simplified intraoral scanning experience. Already recognized as one of the best all-around, most cost-effective intraoral scanner to hit the market, buzz continues to build about Intelliscan 3D as Dental Products Report named Intelliscan 3D as its Editor's Choice for Intraoral Scanners.
SoftWave Tissue Regeneration Technologies patented extracorporeal shock wave device called the OrthGold 100® was cleared by the FDA on May 4, 2021, for the indications of a temporary increase in local blood circulation, relief of minor aches and pains, and activation of connective tissue. (FDA 510(k) letter-number K210451.)
IndyGeneUS AI (pronounced indigenous) has acquired genomic research and testing capabilities through partnerships.